Molecular Partners grants Allergan exclusive, worldwide rights to develop and commercialize abicipar pegol (AGN-150998, MP0112) for ophthalmic indications

Molecular Partners AG

Switzerland / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Allergan Inc.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced